Article Versions Notes

Sicras Mainar A, Salazar-Mendiguchía J, del Campo Alonso MI, Echeto A, Vilanova Larena D, Comín Colet J. Consequences of the Poor Anticoagulation Control of Patients with Non-Valvular Atrial Fibrillation Treated with Vitamin K Antagonists. Journal of Clinical Medicine. 2024; 13(21):6495. https://doi.org/10.3390/jcm13216495

Sicras Mainar, Antoni, Joel Salazar-Mendiguchía, María Isabel del Campo Alonso, Ainara Echeto, David Vilanova Larena, and Josep Comín Colet. 2024. "Consequences of the Poor Anticoagulation Control of Patients with Non-Valvular Atrial Fibrillation Treated with Vitamin K Antagonists" Journal of Clinical Medicine 13, no. 21: 6495. https://doi.org/10.3390/jcm13216495

Sicras Mainar, A., Salazar-Mendiguchía, J., del Campo Alonso, M. I., Echeto, A., Vilanova Larena, D., & Comín Colet, J. (2024). Consequences of the Poor Anticoagulation Control of Patients with Non-Valvular Atrial Fibrillation Treated with Vitamin K Antagonists. Journal of Clinical Medicine, 13(21), 6495. https://doi.org/10.3390/jcm13216495